ZA200903626B - DMAE as sole agent for the treatment of mild cognitive impairment - Google Patents

DMAE as sole agent for the treatment of mild cognitive impairment

Info

Publication number
ZA200903626B
ZA200903626B ZA200903626A ZA200903626A ZA200903626B ZA 200903626 B ZA200903626 B ZA 200903626B ZA 200903626 A ZA200903626 A ZA 200903626A ZA 200903626 A ZA200903626 A ZA 200903626A ZA 200903626 B ZA200903626 B ZA 200903626B
Authority
ZA
South Africa
Prior art keywords
dmae
treatment
cognitive impairment
mild cognitive
sole agent
Prior art date
Application number
ZA200903626A
Other languages
English (en)
Inventor
Pierre Fabre
Christophe Przybylski
Bruno Dubois
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of ZA200903626B publication Critical patent/ZA200903626B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200903626A 2006-10-31 2009-05-26 DMAE as sole agent for the treatment of mild cognitive impairment ZA200903626B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0609548A FR2907679B1 (fr) 2006-10-31 2006-10-31 Utilisation de dmae pour le traitement de deficit cognitif leger

Publications (1)

Publication Number Publication Date
ZA200903626B true ZA200903626B (en) 2010-07-28

Family

ID=38050144

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903626A ZA200903626B (en) 2006-10-31 2009-05-26 DMAE as sole agent for the treatment of mild cognitive impairment

Country Status (18)

Country Link
US (1) US8207218B2 (es)
EP (1) EP2083814B1 (es)
JP (1) JP2010508253A (es)
KR (1) KR20090082428A (es)
CN (1) CN101528220A (es)
AR (1) AR063764A1 (es)
AU (1) AU2007316137A1 (es)
BR (1) BRPI0718263A2 (es)
CA (1) CA2667983A1 (es)
FR (1) FR2907679B1 (es)
IL (1) IL198463A0 (es)
MA (1) MA30925B1 (es)
MX (1) MX2009004682A (es)
NO (1) NO20092099L (es)
RU (1) RU2009120137A (es)
TN (1) TN2009000159A1 (es)
WO (1) WO2008053011A1 (es)
ZA (1) ZA200903626B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150157046A1 (en) * 2013-12-10 2015-06-11 Lifewave, Inc. Nutritional product composition for the mind

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
US20060211721A1 (en) * 2005-03-21 2006-09-21 Roberts Alan R Nutraceutical formulation of a cognitive enhancement system

Also Published As

Publication number Publication date
WO2008053011A1 (fr) 2008-05-08
US8207218B2 (en) 2012-06-26
NO20092099L (no) 2009-07-17
FR2907679A1 (fr) 2008-05-02
FR2907679B1 (fr) 2009-10-30
IL198463A0 (en) 2010-02-17
RU2009120137A (ru) 2010-12-10
EP2083814B1 (fr) 2013-03-20
EP2083814A1 (fr) 2009-08-05
BRPI0718263A2 (pt) 2014-01-07
AR063764A1 (es) 2009-02-18
CA2667983A1 (fr) 2008-05-08
JP2010508253A (ja) 2010-03-18
AU2007316137A1 (en) 2008-05-08
US20090298908A1 (en) 2009-12-03
MA30925B1 (fr) 2009-11-02
KR20090082428A (ko) 2009-07-30
TN2009000159A1 (fr) 2010-10-18
CN101528220A (zh) 2009-09-09
MX2009004682A (es) 2009-09-28

Similar Documents

Publication Publication Date Title
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
EP1871331A4 (en) COMPOSITION FOR THE TREATMENT OF MENOPAUSE
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
EP2046315A4 (en) THERAPEUTIC AGENTS FOR THE TREATMENT OF LYMPHOID MALIGNANCIES
PL1905452T3 (pl) Środek do zapobiegania lub leczenia jaskry
EP2060264A4 (en) AGENT FOR TREATING OCULAR DISEASES
HK1136966A1 (zh) 用於皮膚消毒的溫和組合物
IL193747A0 (en) New therapeutic combinations for the treatment of depression
IL190779A0 (en) Compositions for treatment of eye diseases
EP1965827A4 (en) TREATMENT OF CONDITIONS RELATED TO DEMYELINATION
WO2008155533A3 (en) Phenothiazine compounds for treating mild cognitive impairment
ZA201006087B (en) Kit, composition, product or medicament for treating cognitive impairment
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
EP1950209A4 (en) TREATMENT AGENT FOR CIRCULATORY INSUFFICIENCY
GB0909297D0 (en) Composition for the treatment of skin conditions
EP1867640A4 (en) MEANS FOR TREATING SOLID TUMORS
EP1870404A4 (en) MEANS FOR THE TREATMENT OF A HEMATOPOIETIC TUMOR
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP1890711A4 (en) COMPOUNDS FOR THE TREATMENT OR PREVENTION OF AMINOXIDASE-RELATED DISEASES OR DISEASES
EP1857119A4 (en) AGENT FOR THE PREVENTION / TREATMENT OF NEURODEGENERATIVE DISEASE
ZA200903626B (en) DMAE as sole agent for the treatment of mild cognitive impairment
AP2007004297A0 (en) Method of combating bugs
HU0500947D0 (en) Composition for treatment of paradontosis
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
GB0705674D0 (en) Composition for the treatment of halitosis